Accessibility Menu

Genomma Lab InternacionalB. De C.v.(FRA) GEKA

Market Cap€665.00MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€0.67
+0.00%
+0.00Today

Genomma Lab InternacionalB. De C.v. Financials at a Glance

Market Cap

€665.00MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€813.92

Net Income (TTM)

€77.53

EPS (TTM)

€0.08

P/E Ratio

8.36

Dividend

€0.04

Beta (Volatility)

0.07 (Low)

Price

€0.67

Volume

0

Open

€0.67

Previous Close

€0.67

Daily Range

€0.67 - €0.67

52-Week Range

€0.66 - €1.03

Estimated Earnings Date

N/A

GEKA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Genomma Lab InternacionalB. De C.v.

Genomma Lab Internacional SAB de CV engages in the development, manufacturing and marketing of pharmaceutical, beauty and personal care products. The company was founded by Rodrigo Alonso Herrera Aspra on October 30, 1996 and is headquartered in Mexico City, Mexico.

Industry

Pharmaceuticals

Employees

1,658

CEO

Marco Sparvieri

GEKA Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

14.15%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

11.96%

Dividend Yield

5.77%

Payout Ratio

N/A

Stock Overview

Market Cap

€665.00MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.00B

Volume

0

Avg. Volume

43.318

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Genomma Lab InternacionalB. De C.v. Performance Analysis

Genomma Lab InternacionalB. De C.v. annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 795,304,69823.2%
20232023-12-31EUR 858,565,4108.0%
20242024-12-31EUR 938,434,4869.3%
20252025-12-31EUR 809,500,206-13.7%
Genomma Lab InternacionalB. De C.v. annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 0.0722.2%
20232023-12-31EUR 0.06-15.4%
20242024-12-31EUR 0.0837.7%
20252025-12-31EUR 0.08-0.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€217.40

+1.0%

Gross Profit

€140.35

+1.0%

Gross Margin

64.56%

+1.0%

Market Cap

€665.00MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€0.44

+0.8%

Employees

1,658

+1.0%

Net Income

€18.52

+1.2%

EBITDA

€47.63

+1.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€513.65

+16.2%

Total Debt

€392.89

+1.2%

Accounts Receivable

€268.95

+1.1%

Inventory

€119.97

+1.0%

Long Term Debt

€120.83

+0.5%

Short Term Debt

€272.06

+2.7%

Return on Assets

6.73%

+0.8%

Return on Invested Capital

10.52%

+1.0%

Free Cash Flow

€5.57

+0.4%

Operating Cash Flow

€11.60

+0.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About GEKA

What is the current price of Genomma Lab InternacionalB. De C.v.?

Genomma Lab InternacionalB. De C.v. is trading at €0.67 per share.

What is the 52-week range for Genomma Lab InternacionalB. De C.v.?

Over the past 52 weeks, Genomma Lab InternacionalB. De C.v. has traded between €0.66 and €1.03.

How much debt does Genomma Lab InternacionalB. De C.v. have?

As of the most recent reporting period, Genomma Lab InternacionalB. De C.v. reported total debt of €392.89M.

How much cash does Genomma Lab InternacionalB. De C.v. have on hand?

Genomma Lab InternacionalB. De C.v. reported €120.76M in cash and cash equivalents in its most recent financial results.

What is Genomma Lab InternacionalB. De C.v.’s dividend yield?

Genomma Lab InternacionalB. De C.v. currently has a dividend yield of 5.77%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.